MeiraGTx's Grant

MeiraGTx raised a round of funding on February 01, 2017. Investors include Target ALS.

MeiraGTx (NASDAQ:MGTX) is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company is pioneering the use of …

Articles about MeiraGTx's Grant: